Hikma Pharmaceuticals PLC (HIK) — Free Cash Flow Generation Index
Hikma Pharmaceuticals PLC (HIK) has a Free Cash Flow Generation Index of 0.58x as of June 2025. Free cash flow of GBX93.00 Million represents 1% of operating cash flow (GBX161.00 Million). Explore capital reinvestment ratio of Hikma Pharmaceuticals PLC to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Hikma Pharmaceuticals PLC Free Cash Flow Generation Index (2002–2024)
Historical FCF Generation Index trend for Hikma Pharmaceuticals PLC across 23 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Hikma Pharmaceuticals PLC.
Annual Free Cash Flow Generation for Hikma Pharmaceuticals PLC (2002–2024)
Year-by-year Free Cash Flow Generation Index for Hikma Pharmaceuticals PLC. Check Hikma Pharmaceuticals PLC (HIK) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (GBX) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.71x | GBX399.00 Million | GBX564.00 Million | GBX165.00 Million | ▼ -2.0% |
| 2023 | 0.72x | GBX439.00 Million | GBX608.00 Million | GBX169.00 Million | ▲ +25.5% |
| 2022 | 0.58x | GBX305.00 Million | GBX530.00 Million | GBX225.00 Million | ▼ -10.2% |
| 2021 | 0.64x | GBX409.00 Million | GBX638.00 Million | GBX229.00 Million | ▲ +23.9% |
| 2020 | 0.52x | GBX240.00 Million | GBX464.00 Million | GBX224.00 Million | ▼ -14.6% |
| 2019 | 0.61x | GBX286.00 Million | GBX472.00 Million | GBX186.00 Million | ▼ -19.3% |
| 2018 | 0.75x | GBX323.00 Million | GBX430.00 Million | GBX107.00 Million | ▼ -1.0% |
| 2017 | 0.76x | GBX336.00 Million | GBX443.00 Million | GBX107.00 Million | ▲ +30.0% |
| 2016 | 0.58x | GBX171.00 Million | GBX293.00 Million | GBX122.00 Million | ▼ -24.8% |
| 2015 | 0.78x | GBX284.00 Million | GBX366.00 Million | GBX82.00 Million | ▼ -1.3% |
| 2014 | 0.79x | GBX334.00 Million | GBX425.00 Million | GBX91.00 Million | ▼ -4.7% |
| 2013 | 0.82x | GBX278.00 Million | GBX337.00 Million | GBX59.00 Million | ▲ +63.4% |
| 2012 | 0.50x | GBX91.97 Million | GBX182.16 Million | GBX90.19 Million | ▲ +110.3% |
| 2011 | 0.24x | GBX24.64 Million | GBX102.64 Million | GBX78.00 Million | ▼ -61.1% |
| 2010 | 0.62x | GBX85.59 Million | GBX138.79 Million | GBX53.20 Million | ▼ -0.1% |
| 2009 | 0.62x | GBX65.14 Million | GBX105.52 Million | GBX40.38 Million | ▲ +567.2% |
| 2008 | -0.13x | GBX-7.65 Million | GBX57.87 Million | GBX65.52 Million | ▲ +52.0% |
| 2007 | -0.28x | GBX-11.87 Million | GBX43.12 Million | GBX54.99 Million | ▲ +63.2% |
| 2006 | -0.75x | GBX-22.45 Million | GBX29.99 Million | GBX52.44 Million | ▼ -380.5% |
| 2005 | 0.27x | GBX8.73 Million | GBX32.71 Million | GBX23.98 Million | ▼ -23.9% |
| 2004 | 0.35x | GBX11.51 Million | GBX32.84 Million | GBX21.33 Million | ▼ -64.9% |
| 2003 | 1.00x | GBX18.35 Million | GBX18.35 Million | GBX0.00 | ▲ +0.0% |
| 2002 | 1.00x | GBX14.35 Million | GBX14.35 Million | GBX0.00 | — |